Oral small molecule
Bezisterim (NE3107)
Studied in Parkinson’s disease and Long COVID, with prior research in Alzheimer’s disease and exploratory analyses related to epigenetics and biological age.
- Parkinson’s disease — Phase 2 research
- Long COVID — Phase 2 research
- Alzheimer’s disease — prior clinical research
- Longevity and epigenetics — exploratory biomarker research
Continuous infusion terlipressin
BIV201
Designed for investigation in refractory ascites due to liver cirrhosis, with the goal of slowing fluid reaccumulation and reducing procedure burden.
- Refractory ascites — clinical development
- Portable pump delivery concept
- FDA Fast Track and Orphan Drug designations reported by BioVie
How to read the pipeline
Development stages describe where a program is in research; they do not establish safety, efficacy or likelihood of approval. Timelines can change based on data, regulatory feedback, financing and operational considerations.
Development-stage information can change. Investigational candidates are not approved, and safety and efficacy have not been established. Review source documents and current regulatory disclosures.
